Scientists hunt for clues to make cancer cell therapy last longer
NCT ID NCT07342179
Summary
This study aims to understand why some multiple myeloma patients respond better to CAR-T cell therapy than others. Researchers will track 60 patients receiving this advanced treatment, collecting blood and bone marrow samples over one year to identify immune markers that predict treatment success. The goal is to learn what makes these modified immune cells persist longer in the body, which could help doctors personalize future cancer treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu de Poitiers
RECRUITINGPoitiers, 86000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.